ARCHIVES

Wyden Asks Healy To Clarify CRADA Pricing Clause

This article is from The Cancer Letter archive.

Vol. 18 No. 01 | January 3, 1992

Download PDF Visit The Full Archive

Related Articles

Aggressive, Tailored Therapy Improves Survival, Study Finds

October 31, 2008

NIH Biennial Report Offers Research Portrait

September 24, 2010

NTP Bioassay Reports Will Include Other Tests In Assessing Potential Human Risk

January 23, 1981

Funding Opportunities.

April 12, 2002

Cancer Genetics: risk from Three BRCA Mutations Lower Than Expected, NCI Finds

May 23, 1997

Tivozanib Trumps Sorafenib In 1st-Line Renal Cancer Study

May 25, 2012